Successful treatment of atypical mycobacterial meningitis by fluoroquinolone

J Neurol Sci. 1996 Nov;143(1-2):170-2. doi: 10.1016/s0022-510x(96)00181-5.

Abstract

We report a case of restricted meningeal infection by atypical mycobacteria, identified by the polymerase chain reaction, in a non-immunocompromised adult successfully treated by multiple antibiotics including fluoroquinolone. New quinolones should be considered as a therapeutic option for such mycobacterial meningitis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adult
  • Amikacin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Infective Agents / administration & dosage*
  • Antibiotics, Antitubercular / administration & dosage
  • Antitubercular Agents / administration & dosage
  • Cycloserine / administration & dosage
  • Ethambutol / administration & dosage
  • Humans
  • Injections, Spinal
  • Isoniazid / administration & dosage
  • Male
  • Meningitis / drug therapy*
  • Meningitis / microbiology*
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Mycobacterium avium Complex / genetics
  • Mycobacterium avium Complex / isolation & purification*
  • Ofloxacin / administration & dosage
  • Polymerase Chain Reaction
  • Rifampin / administration & dosage
  • Streptomycin / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibiotics, Antitubercular
  • Antitubercular Agents
  • Amikacin
  • Ethambutol
  • Cycloserine
  • Ofloxacin
  • Isoniazid
  • Rifampin
  • Streptomycin